Details for New Drug Application (NDA): 072113
✉ Email this page to a colleague
The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 072113
Tradename: | HALOPERIDOL |
Applicant: | Watson Labs |
Ingredient: | haloperidol |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072113
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Aug 27, 1991 | TE: | RLD: | No |
Complete Access Available with Subscription